Clinical Trials Directory

Trials / Completed

CompletedNCT04343339

Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment

Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment - EPILOGUE

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current containment linked to COVID-19 will have consequences for people suffering from addiction and there is a risk of overdoses when the containment ends. So the investigators hypothesize that this health crisis is an opportunity to develop risk reduction and access to care for vulnerable people who lives with an addiction. The main objective of this study is to describe the changes in the psychoactive substances consumption during the containment in people suffering from addiction. The secondary objectives are to describe the evolution at 1 month from the end of the containment of problematic consumption and the level of access to care of these users

Conditions

Timeline

Start date
2020-04-08
Primary completion
2020-07-30
Completion
2020-09-30
First posted
2020-04-13
Last updated
2020-10-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04343339. Inclusion in this directory is not an endorsement.